Cambridge biotech firm Sage Therapeutics is laying off most of its employees after announcing its planned acquisition earlier this month. Sage will cut 338 jobs effective Aug. 22, according to state ...

We recently compiled a list of the 13 Best Psychedelic Stocks to Invest in Now. Sage Therapeutics, Inc. is placed second among them. Sage Therapeutics, Inc. (NASDAQ:SAGE) known for its FDA-approved ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (SAGE), today reported business highlights and financial results for the second quarter ended June 30, 2025. “Our second quarter results ...

Investors might want to bet on Sage Therapeutics, Inc. (SAGE), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

A Massachusetts biotechnology company developing drugs to treat postpartum depression will lay off its staff of more than 300 after being purchased by another firm. Sage Therapeutics, founded in ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Less than two weeks after ...

Supernus Pharmaceuticals has acquired Sage Therapeutics, strengthening its neuropsychiatry product portfolio. In June 2025, Supernus and Sage entered a definitive agreement for the acquisition, with ...

Sage Therapeutics, Inc. (SAGE) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to a loss of $1.7 per share a year ago. These ...

ROCKVILLE, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (SUPN), a Delaware corporation (NASDAQ: SUPN) ("Supernus", and the "Company"), today announced that the required ...

With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals ...

Shares of specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) jumped 3.1% in the morning session after Cantor Fitzgerald upgraded the stock to Overweight from Neutral and raised ...